Ligand validation:3RX8

9MR: (3R,4R,5R)-3-hydroxy-5-(hydroxymethyl)piperidin-4-yl beta-D-glucopyranoside

9MR is a Ligand Of Interest in 3RX8 designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
3RX8_9MR_A_603	62%	1%	0.144	0.935	2.36	6.39	8	17	4	0	100%	1
3RX8_9MR_A_601	52%	1%	0.163	0.921	2.42	5.35	7	10	5	0	100%	1
3RX7_9MR_A_605	72%	2%	0.116	0.94	3.68	2.95	10	12	0	0	100%	1
2OYK_9MR_A_600	95%	68%	0.066	0.969	0.54	0.7	-	-	0	0	100%	1
3CUF_9MR_A_316	80%	43%	0.095	0.942	1.07	1.14	2	3	0	0	100%	1
5VMA_9MR_A_803	25%	5%	0.163	0.799	1.65	3.54	6	15	0	0	100%	0.92

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.